Abstract

Is a high baseline inflammatory burden the major driver in causing daptomycin-induced eosinophilic pneumonia and muscular toxicity?

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
621. Pharmacokinetics Determinant and Risk Factors of Daptomycin Induced Eosinophilic Pneumonia and Muscular Toxicity: A Survival Analysis in patients treated for Bone and Joint Infection.
Laurent Bourguignon ... Romain Garreau
Open Forum Infectious Diseases | VOL. 9
Laurent Bourguignon, et. al.Laurent Bourguignon ... Romain Garreau
15 Dec 2022
Eosinophilic pneumonia caused by daptomycin: Six cases from two institutions and a review of the literature.
Yuka Yamagishi ... Hiroe Hashioka
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | VOL. 23
Yuka Yamagishi, et. al.Yuka Yamagishi ... Hiroe Hashioka
18 Dec 2016
Seventeen Cases of Daptomycin-Induced Eosinophilic Pneumonia in a Cohort of Patients Treated for Bone and Joint Infections: Proposal for a New Algorithm.
Sylvain Goutelle ... Vincent Cottin
Open forum infectious diseases | VOL. 9
Sylvain Goutelle, et. al.Sylvain Goutelle ... Vincent Cottin
02 Nov 2022
Daptomycin Exposure as a Risk Factor for Daptomycin-Induced Eosinophilic Pneumonia and Muscular Toxicity.
Laurent Bourguignon ... Aurélien Millet
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | VOL. 77
Laurent Bourguignon, et. al.Laurent Bourguignon ... Aurélien Millet
19 Jul 2023
View more papers

More From: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Paper Title
Journal
Date
Author
Correction to: IWGDF/IDSA Guidelines on the Diagnosis and Treatment of Diabetes-related Foot Infections (IWGDF/IDSA 2023).
-
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | VOL. -
--
29 May 2024
The study design and methodology of antibiotic duration in hematological patients with pseudomonas aeruginosa bloodstream infection.
Xiaomeng Feng ... Sizhou Feng
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | VOL. -
Xiaomeng Feng, et. al.Xiaomeng Feng ... Sizhou Feng
29 May 2024
Tenofovir Alafenamide versus Tenofovir Disoproxil Fumarate for Preventing Vertical Transmission in Chronic Hepatitis B Mothers: A Systematic Review and Meta-Analysis.
Calvin Q Pan ... Erhei Dai
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | VOL. -
Calvin Q Pan, et. al.Calvin Q Pan ... Erhei Dai
28 May 2024
Development of Next-Generation COVID-19 Vaccines: BARDA Supported Phase 2b Study Designs.
Daniel N Wolfe ... Huyen Cao
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | VOL. -
Daniel N Wolfe, et. al.Daniel N Wolfe ... Huyen Cao
28 May 2024
View more papers